Yili Chen

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Traditional Chinese medicine and treatmentsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 04, 2025
Mitochondrial sORF-Encoded Peptide MODICA Protects the Heart From Doxorubicin-Induced Cardiac Injury by Suppressing VDAC Oligomerization.

Jialing Wu, Kang Li, Youchen Yan

|Mar 31, 2025
Direct Oral Anticoagulants vs. Vitamin K Antagonists for Atrial Fibrillation in Cardiac Amyloidosis: A Systematic Review and Meta-analysis.

Qinling Nong, Shucheng Liang, Wengen Zhu

|Feb 08, 2025
Association Between Age at Diagnosis of Atrial Fibrillation and Subsequent Risk of Ischemic Stroke.

Yun-Jiu Cheng, Hai Deng, Hui-Qiang Wei

|Mar 14, 2024
Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study.

Gang Yuan, Yili Chen, Li Li

|Dec 12, 2023
Higher Cumulative Blood Pressure in Midlife Predicts an Increased Risk of Atrial Fibrillation: Evidence From the Atherosclerosis Risk in Communities Study.

Yun-Jiu Cheng, Hai Deng, Yun Ling

|Mar 10, 2023
Periprocedural, short-term, and long-term outcomes following transcatheter tricuspid valve repair: a systemic review and meta-analysis.

Zexuan Wu, Wengen Zhu, Wulamiding Kaisaier

Pageof 1

Frequent Collaborators

2 joint publications

Yun-Jiu Cheng

2 joint publications

Wei-Dong Lin

2 joint publications

Zhuomin Liang

2 joint publications

Yu-Mei Xue